{"id":"kedbumin-25","safety":{"commonSideEffects":[{"rate":null,"effect":"Hypervolemia / fluid overload"},{"rate":null,"effect":"Hypersensitivity reactions"},{"rate":null,"effect":"Fever"},{"rate":null,"effect":"Chills"},{"rate":null,"effect":"Nausea"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Human serum albumin is a plasma protein that maintains colloid osmotic pressure, regulates fluid distribution between intravascular and extravascular compartments, and transports various substances including hormones, fatty acids, and drugs. Kedbumin 25% is a concentrated albumin preparation used to restore blood volume and plasma protein levels in patients with hypoproteinemia or acute blood loss. It helps maintain hemodynamic stability and tissue perfusion in critically ill patients.","oneSentence":"Kedbumin 25% is a human serum albumin solution that restores and maintains oncotic pressure and serves as a carrier protein for endogenous and exogenous substances in the bloodstream.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:50:57.766Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hypoproteinemia and hypovolemia in critically ill patients"},{"name":"Acute blood loss and hemorrhagic shock"},{"name":"Severe burns"},{"name":"Liver cirrhosis with ascites"},{"name":"Nephrotic syndrome"}]},"trialDetails":[{"nctId":"NCT04476901","phase":"PHASE2","title":"Administration of Allogeneic-MSC in Patients With Non-Ischemic Dilated Cardiomyopathy","status":"RECRUITING","sponsor":"Joshua M Hare","startDate":"2021-05-07","conditions":"Non-ischemic Dilated Cardiomyopathy","enrollment":136},{"nctId":"NCT02922413","phase":"PHASE2","title":"Panhematin for Prevention of Acute Attacks of Porphyria","status":"TERMINATED","sponsor":"The University of Texas Medical Branch, Galveston","startDate":"2015-10-30","conditions":"Acute Intermittent Porphyria, Hereditary Coproporphyria, Variegate Porphyria","enrollment":13},{"nctId":"NCT07263308","phase":"PHASE3","title":"Albumin for Patients With Acute Large Vessel Occlusive Stroke Undergoing Endovascular Therapy -2","status":"RECRUITING","sponsor":"Capital Medical University","startDate":"2025-12-18","conditions":"Acute Ischemic Stroke","enrollment":1192},{"nctId":"NCT07320430","phase":"NA","title":"Comparative Study Between Sclerosing Agents Used in Treatment of Vascular Malformation","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2024-02-14","conditions":"Vascular Malformation","enrollment":75},{"nctId":"NCT07020715","phase":"PHASE2","title":"A Phase IIa Study of Vitamin D3 Tolerogenic Dendritic Cells (tolDC) for Multiple Sclerosis","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Antwerp","startDate":"2026-03-01","conditions":"Multiple Sclerosis","enrollment":14},{"nctId":"NCT04701034","phase":"PHASE2","title":"Intravenous Immunoglobulin and Prednisolone for RPL After ART.","status":"COMPLETED","sponsor":"Aalborg University Hospital","startDate":"2021-01-28","conditions":"Habitual Abortion, Recurrent Pregnancy Loss, Fertility Disorders","enrollment":80},{"nctId":"NCT02725060","phase":"NA","title":"Autoimmune Basis for Postural Tachycardia Syndrome","status":"ENROLLING_BY_INVITATION","sponsor":"Vanderbilt University Medical Center","startDate":"2016-02","conditions":"Postural Orthostatic Tachycardia Syndrome, Postural Tachycardia Syndrome, Tachycardia","enrollment":58},{"nctId":"NCT04216784","phase":"PHASE4","title":"Compare the Diuretic Effect With Furosemide vs Furosemide and Albumin Combined in Cirrhotic Patients","status":"TERMINATED","sponsor":"Rush University Medical Center","startDate":"2019-12-19","conditions":"Cirrhosis, Liver, Volume Overload, Fluid Overload","enrollment":21},{"nctId":"NCT06715605","phase":"PHASE2","title":"A Clinical Trial Evaluating the Safety and Efficacy of Myelin-peptide Loaded tolDC as Treatment for MS","status":"WITHDRAWN","sponsor":"University Hospital, Antwerp","startDate":"2025-04-30","conditions":"Multiple Sclerosis","enrollment":""},{"nctId":"NCT00936819","phase":"PHASE2","title":"The Enhanced Angiogenic Cell Therapy - Acute Myocardial Infarction Trial","status":"ACTIVE_NOT_RECRUITING","sponsor":"Ottawa Hospital Research Institute","startDate":"2013-07-19","conditions":"Anterior Wall Myocardial Infarction","enrollment":47},{"nctId":"NCT07119463","phase":"PHASE2","title":"Effect of Goal-Oriented Albumin Infusion on Postoperative Complication Management in Gastric Cancer Surgery","status":"RECRUITING","sponsor":"The First Hospital of Jilin University","startDate":"2024-10-29","conditions":"Postoperative Hypoalbuminemia, Postoperative Complications, Gastric Cancer","enrollment":112},{"nctId":"NCT05775198","phase":"NA","title":"Effect of Intrauterine Administration of Autologous PBMC Modulated With IFNt on IVF Outcome","status":"RECRUITING","sponsor":"Nadezhda Women's Health Hospital","startDate":"2023-03-01","conditions":"Infertility, Female, IVF","enrollment":300},{"nctId":"NCT06538844","phase":"PHASE2","title":"Albumin for Patients With Acute Large Vessel Occlusive Stroke Undergoing Endovascular Reperfusion Therapy","status":"COMPLETED","sponsor":"Capital Medical University","startDate":"2024-08-10","conditions":"Acute Ischemic Stroke","enrollment":134},{"nctId":"NCT02808182","phase":"NA","title":"Postprandial Fatty Acid Metabolism in the Natural History of Type 2 Diabetes (T2D)","status":"COMPLETED","sponsor":"Université de Sherbrooke","startDate":"2017-01-17","conditions":"Impaired Glucose Tolerance","enrollment":50},{"nctId":"NCT02673931","phase":"NA","title":"GLP-1 and Hyperoxia for Organ Protection in Heart Surgery","status":"ACTIVE_NOT_RECRUITING","sponsor":"Rigshospitalet, Denmark","startDate":"2016-02","conditions":"Coronary Disease, Shock, Cardiogenic, Renal Failure","enrollment":1400},{"nctId":"NCT06219096","phase":"NA","title":"Application of ICG@HSA Complexes in Fluorescence Image-Guided Laparoscopic Anatomical Liver Resection","status":"RECRUITING","sponsor":"West China Hospital","startDate":"2023-12-10","conditions":"Malignant Tumor of Liver, Randomized Controlled Trial","enrollment":100},{"nctId":"NCT01531803","phase":"PHASE4","title":"Safety Study of Kedbumin 25% Versus Normal Saline in the Treatment of Post-Surgical Hypovolemia in Pediatric Patients","status":"TERMINATED","sponsor":"Kedrion S.p.A.","startDate":"2015-02-05","conditions":"Hypovolemia","enrollment":3},{"nctId":"NCT00006046","phase":"PHASE1","title":"Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal Cancer","status":"TERMINATED","sponsor":"Ludwig Institute for Cancer Research","startDate":"2000-07-12","conditions":"Colorectal Cancer","enrollment":7},{"nctId":"NCT04034316","phase":"PHASE2","title":"Reduce Immunosuppression With Atmp in NS ChildrEn","status":"COMPLETED","sponsor":"Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico","startDate":"2018-11-02","conditions":"Nephrotic Syndrome in Children, Steroid-Dependent Nephrotic Syndrome, Idiopathic Nephrotic Syndrome","enrollment":20},{"nctId":"NCT02097121","phase":"PHASE3","title":"OnabotulinumtoxinA for the Treatment of Urinary Incontinence Due to Overactive Bladder in Pediatric Patients (12 to 17)","status":"TERMINATED","sponsor":"Allergan","startDate":"2014-05-23","conditions":"Urinary Incontinence, Urinary Bladder, Overactive","enrollment":56},{"nctId":"NCT01436292","phase":"PHASE4","title":"Hypoalbuminemia in Burn Patients","status":"WITHDRAWN","sponsor":"Centre hospitalier de l'Université de Montréal (CHUM)","startDate":"2011-09","conditions":"Second or Third Degree Burns","enrollment":""},{"nctId":"NCT03585257","phase":"PHASE2","title":"HEAL STUDY (Hepatic Encephalopathy and Albumin Study)","status":"COMPLETED","sponsor":"Hunter Holmes Mcguire Veteran Affairs Medical Center","startDate":"2018-06-20","conditions":"Cirrhosis, Hepatic Encephalopathy, Minimal Hepatic Encephalopathy","enrollment":48},{"nctId":"NCT02815943","phase":"NA","title":"Postprandial Metabolism After Bariatric Surgery in Type 2 Diabetes","status":"COMPLETED","sponsor":"Université de Sherbrooke","startDate":"2015-08","conditions":"Type 2 Diabetes, Obese","enrollment":18},{"nctId":"NCT01547117","phase":"NA","title":"Dietary Salt in Postural Tachycardia Syndrome","status":"COMPLETED","sponsor":"Vanderbilt University","startDate":"2012-03","conditions":"Postural Orthostatic Tachycardia Syndrome","enrollment":38},{"nctId":"NCT01563107","phase":"NA","title":"Dietary Sodium's Effect on Urinary Sodium and Dopamine Excretion in Patients With Postural Tachycardia Syndrome","status":"COMPLETED","sponsor":"Vanderbilt University Medical Center","startDate":"2012-03","conditions":"Postural Orthostatic Tachycardia Syndrome","enrollment":38},{"nctId":"NCT03656198","phase":"PHASE4","title":"Non-specific Effects of Rabies Vaccine","status":"COMPLETED","sponsor":"Ross University School of Veterinary Medicine","startDate":"2018-08-29","conditions":"Influenza-like Illness, Upper Respiratory Disease, Diarrhea","enrollment":546},{"nctId":"NCT00666263","phase":"PHASE3","title":"Study of the Effectiveness of Intravenous Immune Globulin (10%) for the Treatment of Multifocal Motor Neuropathy","status":"COMPLETED","sponsor":"Baxalta now part of Shire","startDate":"2008-08-22","conditions":"Multifocal Motor Neuropathy","enrollment":50},{"nctId":"NCT02975726","phase":"NA","title":"Peritoneal Dialysis Catheters for the Treatment of Refractory Ascites","status":"COMPLETED","sponsor":"University of Manitoba","startDate":"2017-01","conditions":"Liver Cirrhosis, Ascites","enrollment":2},{"nctId":"NCT02956122","phase":"PHASE2, PHASE3","title":"A Phase 2/3 Study of GLASSIA for the Treatment of Acute GvHD","status":"TERMINATED","sponsor":"Baxalta now part of Shire","startDate":"2017-04-26","conditions":"Graft Versus Host Disease","enrollment":1},{"nctId":"NCT01214317","phase":"NA","title":"Study of Induction Therapy With Mitoxantrone and Plasmapheresis to Treat Aggressive Multiple Sclerosis","status":"COMPLETED","sponsor":"Isfahan University of Medical Sciences","startDate":"2010-01","conditions":"Multiple Sclerosis","enrollment":40},{"nctId":"NCT04313322","phase":"PHASE1","title":"Treatment of COVID-19 Patients Using Wharton's Jelly-Mesenchymal Stem Cells","status":"UNKNOWN","sponsor":"Stem Cells Arabia","startDate":"2020-03-16","conditions":"Use of Stem Cells for COVID-19 Treatment","enrollment":5},{"nctId":"NCT00235495","phase":"PHASE3","title":"Albumin in Acute Ischemic Stroke Trial","status":"TERMINATED","sponsor":"University of Miami","startDate":"2006-06","conditions":"Ischemic Stroke","enrollment":841},{"nctId":"NCT03741270","phase":"PHASE4","title":"Safety of Rabivax-S for Pre-exposure Prophylaxis","status":"COMPLETED","sponsor":"Ross University School of Veterinary Medicine","startDate":"2018-10-24","conditions":"Rabies Vaccine Adverse Reaction","enrollment":159},{"nctId":"NCT01822600","phase":"PHASE4","title":"The Therapeutic Role of Intravenous Albumin Administration for Peptic Ulcer Bleeding Patients With Hypoalbuminemia","status":"COMPLETED","sponsor":"National Cheng-Kung University Hospital","startDate":"2010-01","conditions":"Peptic Ulcer Bleeding, Hypoalbuminemia","enrollment":91},{"nctId":"NCT01849757","phase":"NA","title":"Comparison of Priming Constituents in Patients Undergoing CPB Assisted Cardiac Surgery: HES 130/0.4 or Albumin 5%","status":"WITHDRAWN","sponsor":"University of Saskatchewan","startDate":"2013-11","conditions":"Coronary Artery Disease, Aortic Valve Disease, Mitral Valve Disease","enrollment":""},{"nctId":"NCT03921710","phase":"NA","title":"CAPA-IVM Versus STANDARD IVM","status":"COMPLETED","sponsor":"Mỹ Đức Hospital","startDate":"2017-04-29","conditions":"Infertility, Female","enrollment":80},{"nctId":"NCT01951729","phase":"PHASE1","title":"The Role of Cholinergic Signaling for Mediating the Effects of GIP and/or Xenin-25 on Insulin Secretion","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2013-03-13","conditions":"Pre-diabetes","enrollment":15},{"nctId":"NCT00798915","phase":"PHASE1","title":"Study of the Effects of Xenin-25 in Humans With and Without Type 2 Diabetes Mellitus","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2008-12","conditions":"Diabetes","enrollment":40},{"nctId":"NCT01951716","phase":"PHASE1","title":"Effects of Xenin-25 on Insulin Secretion and Gastric Emptying in Humans With and Without a Complete Truncal Vagotomy","status":"WITHDRAWN","sponsor":"Washington University School of Medicine","startDate":"2013-01","conditions":"Does the Vagus Nerve Mediate the Effects of Xenin-25","enrollment":""},{"nctId":"NCT02442791","phase":"NA","title":"GLP-1 Analogs for Neuroprotection After Cardiac Arrest","status":"COMPLETED","sponsor":"Jesper Kjaergaard","startDate":"2014-06","conditions":"Cardiac Arrest, Coma","enrollment":120},{"nctId":"NCT03031600","phase":"NA","title":"Pilot Validation of a Hemodilution Technique to Estimate Blood Volume in Vivo","status":"UNKNOWN","sponsor":"Uniformed Services University of the Health Sciences","startDate":"2017-05-01","conditions":"Hypovolemia, Hypervolemia","enrollment":33},{"nctId":"NCT00220779","phase":"PHASE2","title":"Immune Globulin Intravenous (IGIV) To Treat Relapsing, Remitting Multiple Sclerosis","status":"COMPLETED","sponsor":"Grifols Therapeutics LLC","startDate":"2002-12","conditions":"Multiple Sclerosis, Relapsing-Remitting","enrollment":128},{"nctId":"NCT00220740","phase":"PHASE3","title":"Immune Globulin Intravenous (IGIV) For Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)","status":"COMPLETED","sponsor":"Grifols Therapeutics LLC","startDate":"2004-04","conditions":"Polyradiculoneuropathy, Chronic Inflammatory Demyelinating","enrollment":117},{"nctId":"NCT00220805","phase":"PHASE2","title":"Use of Immune Globulin Intravenous (Human) To Treat Age-Related Macular Degeneration","status":"COMPLETED","sponsor":"Grifols Therapeutics LLC","startDate":"2004-01","conditions":"Macular Degeneration","enrollment":96},{"nctId":"NCT02167087","phase":"NA","title":"Sentinel Node Mapping With Indocyanine Green in Colon Cancer: a Feasibility Trial and a Descriptive Serie.","status":"COMPLETED","sponsor":"Ismail Gögenür","startDate":"2015-03","conditions":"Colon Cancer, Lymphatic Metastasis","enrollment":30},{"nctId":"NCT01206582","phase":"PHASE2","title":"A Pilot Study of Hemin Therapy for Gastroparesis (Diabetes Mellitus)","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2010-05","conditions":"Gastroparesis, Diabetes Mellitus","enrollment":20},{"nctId":"NCT00283400","phase":"NA","title":"Treatment of Subarachnoid Hemorrhage With Human Albumin","status":"TERMINATED","sponsor":"Baylor College of Medicine","startDate":"2006-01","conditions":"Subarachnoid Hemorrhage","enrollment":47},{"nctId":"NCT00722475","phase":"PHASE3","title":"Trial of the Efficacy of Intravenous Immunoglobulin for Treating Women With Unexplained Secondary Recurrent Miscarriage","status":"COMPLETED","sponsor":"Rigshospitalet, Denmark","startDate":"2008-08","conditions":"Secondary Recurrent Miscarriage","enrollment":82},{"nctId":"NCT02270723","phase":"PHASE4","title":"The Effect of Human Albumin on Coagulation Competence and Hemorrhage","status":"UNKNOWN","sponsor":"Kirsten Cleemann Rasmussen","startDate":"2014-08","conditions":"Hemorrhage; Complicating Delivery, Coagulation Defect","enrollment":40},{"nctId":"NCT00742339","phase":"PHASE2, PHASE3","title":"Terlipressin + Albumin Versus Midodrine + Octreotide in the Treatment of Hepatorenal Syndrome","status":"TERMINATED","sponsor":"University of Padova","startDate":"2005-05","conditions":"Cirrhosis, Hepatorenal Syndrome","enrollment":49},{"nctId":"NCT00990509","phase":"PHASE2","title":"Albumin for Intracerebral Hemorrhage Intervention","status":"TERMINATED","sponsor":"Georgetown University","startDate":"2009-09","conditions":"Intracerebral Hemorrhage","enrollment":14},{"nctId":"NCT00949663","phase":"PHASE1","title":"Xenin-25: Novel Regulator of Insulin Secretion and Beta-cell Function","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2009-10","conditions":"Type 2 Diabetes Mellitus","enrollment":38},{"nctId":"NCT01019681","phase":"PHASE1","title":"Efficacy and Safety of Umbilical Cord Blood Injection for Critical Limb Ischemia","status":"TERMINATED","sponsor":"Richard Burt, MD","startDate":"2009-11","conditions":"Critical Limb Ischemia","enrollment":1},{"nctId":"NCT01747408","phase":"PHASE1","title":"Treatment of Subarachnoid Hemorrhage With Human Albumin","status":"TERMINATED","sponsor":"Baylor College of Medicine","startDate":"2006-06","conditions":"Subarachnoid Hemorrhage","enrollment":47},{"nctId":"NCT01249222","phase":"NA","title":"Pro-inflammatory Cytokines Profile and Mortality Rate of Critically Ill Septic Patients Following Plasmapheresis","status":"UNKNOWN","sponsor":"Tehran University of Medical Sciences","startDate":"2008-11","conditions":"Severe Sepsis","enrollment":27}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Albumin (Human) 25%"],"phase":"marketed","status":"active","brandName":"Kedbumin 25%","genericName":"Kedbumin 25%","companyName":"Kedrion S.p.A.","companyId":"kedrion-s-p-a","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Kedbumin 25% is a treatment that has been studied in clinical trials for various conditions, including COVID-19, coronary disease, shock, cardiogenic shock, renal failure, and stroke. It is administered in combination with other interventions, such as Byetta (exenatide) and Conoxia (oxygen), as part of these trials.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}